These data convincingly demonstrate that miR-378a-3p suppresses HCC sorafenib resistance as an inhibitor of IGF1R to eliminate the IGF1R resistant effect through miR-378a-3p/IGF1R axis. This evidence concerns the gene IGF1R and hepatocellular carcinoma.